person · Reporting owner
Kurzius Lawrence Erik
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COOPER COMPANIES, INC.COO · Entity 3395 | Director | September 16, 2026 | September 17, 2026 |
| Elanco Animal Health IncELAN · Entity 3457 | Director | August 20, 2026 | August 21, 2026 |
| Lamb Weston Holdings, Inc.LW · Entity 3684 | Director | October 08, 2026 | October 09, 2026 |
| MCCORMICK & CO INCMKC · Entity 1416 | 10% owner | August 10, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COOPER COMPANIES, INC.
Report date September 16, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,099 |
Reported balance
After 2026-09-16 transaction · row 1
1 source rowRow 1 · 2026-09-16 · Purchase · Acquired 10,000 · Balance 31,099 |
Elanco Animal Health Inc
Report date August 20, 2026 · Filed August 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 188,647 |
Reported balance
After 2026-08-20 transaction · row 1
1 source rowRow 1 · 2026-08-20 · Purchase · Acquired 40,000 · Balance 188,647 F1: Reflects the weighted average price of 40,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 20, 2026 with purchase prices ranging from $23.385 to $23.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the weighted average price of 40,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 20, 2026 with purchase prices ranging from $23.385 to $23.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Lamb Weston Holdings, Inc.
Report date October 08, 2026 · Filed October 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,054 |
Reported balance
After 2026-10-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-08 · Grant · Acquired 5,458 · Balance 11,054 F1: Represents restricted stock units ("RSUs") that vest on the earlier of (1) the first anniversary of the date of grant and (2) the date of the next annual meeting of Lamb Weston Holdings, Inc.'s ("Lamb Weston") stockholders that is at least 50 weeks after September 16, 2026, or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston common stock upon settlement. F2: Includes 135 additional shares acquired since the date of the reporting person's last report through a dividend reinvestment feature. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") that vest on the earlier of (1) the first anniversary of the date of grant and (2) the date of the next annual meeting of Lamb Weston Holdings, Inc.'s ("Lamb Weston") stockholders that is at least 50 weeks after September 16, 2026, or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston common stock upon settlement.
F2: Includes 135 additional shares acquired since the date of the reporting person's last report through a dividend reinvestment feature.
MCCORMICK & CO INC
Report date August 10, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock - VotingSEC Table I · non-derivative | Direct | 296,992 |
Ending reported balance
After 2026-08-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-10 · Exercise / conversion · Acquired 205,538 · Balance 502,530 Row 2 · 2026-08-10 · Sale · Disposed 205,538 · Balance 296,992 |
| Options - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $49.03 · Expires 2027-03-29 | Direct | 0 |
Reported balance
After 2026-08-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-08-10 · Exercise / conversion · Disposed 205,538 · Balance 0 F1: Option exercised; no purchase price required. |
Filing footnotes · ownership attribution and instrument terms
F1: Option exercised; no purchase price required.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 27, 2019 Filed Dec 2, 2019 21:04 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 6,720 | $167.57 | $1,126,036.80 |
DisclosureSEC source: 0000063754-19-000203 · edgar.xml · nonDerivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,488 Read SEC document |
| November 27, 2019 Filed Dec 2, 2019 21:04 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 14,020 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000063754-19-000203 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units; no purchase price required. Read SEC document |
| October 21, 2019 Filed Nov 14, 2019 15:37 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 50.2857 | $162.38 | $8,165.39 |
DisclosureSEC source: 0000063754-19-000188 · edgar.xml · derivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Non-Qualified Retirement Savings Plan Disclosed balance after: 14,375.4526 Underlying: Common Stock - Voting · 50.2857 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment F1 · derivative.exercise_date: Dividend Reinvestment F1 · derivative.expiration_date: Dividend Reinvestment Read SEC document |
| July 22, 2019 Filed Aug 9, 2019 17:33 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 51.216 | $158.86 | $8,136.17 |
DisclosureSEC source: 0000063754-19-000142 · edgar.xml · derivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Non-Qualified Retirement Savings Plan Disclosed balance after: 14,325.1672 Underlying: Common Stock - Voting · 51.216 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment F1 · derivative.exercise_date: Dividend Reinvestment F1 · derivative.expiration_date: Dividend Reinvestment Read SEC document |
| April 22, 2019 Filed May 13, 2019 20:22 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 53.0942 | $152.67 | $8,105.89 |
DisclosureSEC source: 0000063754-19-000102 · edgar.xml · derivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Non-Qualified Retirement Savings Plan Disclosed balance after: 14,273.9523 Underlying: Common Stock - Voting · 53.0942 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment F1 · derivative.exercise_date: Dividend Reinvestment F1 · derivative.expiration_date: Dividend Reinvestment Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 21:43 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 2,783 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000250 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,579 F1 · price: Grant of deferred stock units to each of the non-employee members of the Issuer's Board of Directors, vesting three years from the date of grant. Read SEC document |
| March 27, 2019 Filed Mar 29, 2019 15:59 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantOptions - Right to Buy · Derivative | 54,526 | $0.00 Strike: $147.39 | $0.00 |
DisclosureSEC source: 0000063754-19-000076 · edgar.xml · derivative · entry 6 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,526 Underlying: Common Stock - Voting · 54,526 shares Expires not disclosed F4 · derivative.exercise_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries. F4 · derivative.expiration_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries. Read SEC document |
| March 27, 2019 Filed Mar 29, 2019 15:59 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantRestricted Stock Units · Derivative | 10,491 | $0.00 | $0.00 |
DisclosureSEC source: 0000063754-19-000076 · edgar.xml · derivative · entry 5 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,491 Underlying: Common Stock - Voting · 10,491 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive on share of Common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three year period beginning March 15, 2020, March 15, 2021 and March 15, 2022. F3 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three year period beginning March 15, 2020, March 15, 2021 and March 15, 2022. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 20:14 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionRestricted Stock Units · Derivative | 4,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000063754-19-000053 · edgar.xml · derivative · entry 8 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,501 Underlying: Common Stock - Votingt · 4,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted Stock Units; no purchase price required. F8 · price: Restricted Stock Units granted on March 28, 2018. F7 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three year period beginning March 15, 2019, March 15, 2020 and March 15, 2021. F7 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three year period beginning March 15, 2019, March 15, 2020 and March 15, 2021. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 20:14 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionRestricted Stock Units · Derivative | 286 | $0.00 | $0.00 |
DisclosureSEC source: 0000063754-19-000053 · edgar.xml · derivative · entry 7 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286 Underlying: Common Stock - Voting · 286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted Stock Units; no purchase price required. F6 · price: Restricted Stock Units granted om March 29, 2017. F5 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three year period beginning March 15, 2018, March 15, 2019 and March 15, 2020 but are subject to deferred delivery based on certain termination of service events. F5 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three year period beginning March 15, 2018, March 15, 2019 and March 15, 2020 but are subject to deferred delivery based on certain termination of service events. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 20:14 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 1,938 | $139.34 | $270,040.92 |
DisclosureSEC source: 0000063754-19-000053 · edgar.xml · nonDerivative · entry 3 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,188 F3 · balance_after: Number reflects an upward adjustment of 138 shares that were previously reported on teh Reporting Person's Form 4 as a disposition; which transaction did not in fact occur. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 20:14 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 4,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000063754-19-000053 · edgar.xml · nonDerivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,988 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted Stock Units; no purchase price required. Read SEC document |
| March 15, 2019 Filed Mar 19, 2019 20:14 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 286 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000063754-19-000053 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Subject to deferred receipt. F2 · price: Restricted Stock Units; no purchase price required. Read SEC document |
| February 14, 2019 Filed Feb 15, 2019 20:36 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 6,715 | $128.68 | $864,052.63 |
DisclosureSEC source: 0000063754-19-000025 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,452 F1 · shares: Shares withheld for taxes on the shares previously reported on 1/23/2019 for McCormick's long-term incentive program. Read SEC document |
| January 21, 2019 Filed Jan 23, 2019 19:05 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantCommon Stock - Voting | 14,008 | $0.00 | $0.00 |
DisclosureSEC source: 0000063754-19-000009 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,167 F1 · shares: Shares awarded pursuant to McCormick's long-term incentive program for the three year performance cycle beginning on December 1, 2015 and ending on November 30, 2018. Read SEC document |
| January 14, 2019 Filed Mar 29, 2019 15:59 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 57.9157 | $139.39 | $8,072.87 |
DisclosureSEC source: 0000063754-19-000076 · edgar.xml · derivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Non-Qualified Retirement Savings Plan Disclosed balance after: 14,220.8581 Underlying: Common Stock - Voting · 57.9157 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment F1 · derivative.exercise_date: Dividend Reinvestment F1 · derivative.expiration_date: Dividend Reinvestment Read SEC document |
| November 30, 2018 Filed Dec 4, 2018 22:27 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 1,796 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-18-000644 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,796 F1 · price: Grant of deferred stock as an annual equity award to independent members of the Board of Directors. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 21:00 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantRestricted Stock Units · Derivative | 42,061 | $0.00 | $0.00 |
DisclosureSEC source: 0000063754-18-000117 · edgar.xml · derivative · entry 5 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,061 Underlying: Common Stock - Voting · 42,061 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units will vest in thirds on the first, second, and third anniversaries of the grant date beginning November 27, 2019, November 27, 2020 and November 27, 2021. F3 · derivative.expiration_date: The Restricted Stock Units will vest in thirds on the first, second, and third anniversaries of the grant date beginning November 27, 2019, November 27, 2020 and November 27, 2021. Read SEC document |
| October 30, 2018 Filed Oct 31, 2018 14:46 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting · Derivative | 51,300 | $0.00 Strike: $54.24 | $0.00 |
DisclosureSEC source: 0000063754-18-000101 · edgar.xml · derivative · entry 6 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock - Voting · 51,300 shares Expires 2022-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Option Exercised. Read SEC document |
| October 30, 2018 Filed Oct 31, 2018 14:46 UTC | MCCORMICK & CO INC MKC · Entity 1416 | SaleCommon Stock - Voting | 51,300 | $142.01 | $7,285,113.00 |
DisclosureSEC source: 0000063754-18-000101 · edgar.xml · nonDerivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,159 Read SEC document |
| October 30, 2018 Filed Oct 31, 2018 14:46 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 51,300 | $54.24 | $2,782,512.00 |
DisclosureSEC source: 0000063754-18-000101 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 23, 2018 Filed Nov 29, 2018 21:00 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 52.0294 | $141.03 | $7,337.71 |
DisclosureSEC source: 0000063754-18-000117 · edgar.xml · derivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Non-Qualified Retirement Savings Plan Disclosed balance after: 14,162.9424 Underlying: Common Stock - Voting · 52.0294 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment F1 · derivative.exercise_date: Dividend Reinvestment F1 · derivative.expiration_date: Dividend Reinvestment Read SEC document |
| September 24, 2018 Filed Sep 26, 2018 20:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 10,000 | $24.00 | $240,000.00 |
DisclosureSEC source: 0001140361-18-039147 · form4.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| July 23, 2018 Filed Aug 17, 2018 16:13 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 62.3314 | $117.20 | $7,305.24 |
DisclosureSEC source: 0000063754-18-000067 · edgar.xml · derivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Non-Qualified Retirement Savings Plan Disclosed balance after: 14,110.913 Underlying: Common Stock - Voting · 62.3314 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment F1 · derivative.exercise_date: Dividend Reinvestment F1 · derivative.expiration_date: Dividend Reinvestment Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 19:04 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionOptions - Right to Buy · Derivative | 58,800 | $0.00 Strike: $47.40 | $0.00 |
DisclosureSEC source: 0000063754-18-000051 · edgar.xml · derivative · entry 6 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock - Voting · 58,800 shares Expires 2021-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Option Exercised. Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 19:04 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 40,307 | $119.71 | $4,824,949.44 |
DisclosureSEC source: 0000063754-18-000051 · edgar.xml · nonDerivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,159 Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 19:04 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 58,800 | $47.40 | $2,787,120.00 |
DisclosureSEC source: 0000063754-18-000051 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2018 Filed Jun 14, 2018 16:21 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 70.0475 | $103.77 | $7,268.83 |
DisclosureSEC source: 0000063754-18-000029 · edgar.xml · derivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Non-Qualified Retirement Savings Plan Disclosed balance after: 14,048.5816 Underlying: Common Stock - Voting · 70.0475 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment F1 · derivative.exercise_date: Dividend Reinvestment F1 · derivative.expiration_date: Dividend Reinvestment Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 13:55 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantOptions - Right to Buy · Derivative | 64,040 | $0.00 Strike: $105.75 | $0.00 |
DisclosureSEC source: 0001314598-18-000069 · edgar.xml · derivative · entry 6 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,040 Underlying: Common Stock - Voting · 64,040 shares Expires 2028-03-27 F4 · derivative.exercise_date: The option grant becomes exercisable in thirds of each of the first three (3) grant anniversaries. Read SEC document |
| March 28, 2018 Filed Mar 30, 2018 13:55 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantRestricted Stock Units · Derivative | 12,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001314598-18-000069 · edgar.xml · derivative · entry 5 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,751 Underlying: Common Stock - Voting · 12,751 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three year period beginning March 15, 2019, March 15, 2020 and March 15, 2021. F3 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three year period beginning March 15, 2019, March 15, 2020 and March 15, 2021. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 19:07 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionRestricted Stock Units · Derivative | 286 | $0.00 | $0.00 |
DisclosureSEC source: 0001314598-18-000053 · edgar.xml · derivative · entry 6 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572 Underlying: Common Stock - Voting · 286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units; no purchase price required. F4 · price: Restricted Stock Units granted on March 29, 2017. F3 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three year period beginning March 15, 2018, March 15, 2019 and March 15, 2020. F3 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three year period beginning March 15, 2018, March 15, 2019 and March 15, 2020. Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 19:07 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 138 | $110.83 | $15,294.18 |
DisclosureSEC source: 0001314598-18-000053 · edgar.xml · nonDerivative · entry 2 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,666 Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 19:07 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 286 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001314598-18-000053 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units; no purchase price required. Read SEC document |
| March 15, 2018 Filed Dec 13, 2018 20:55 UTC Amendment | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionRestricted Stock Units · Derivative | 286 | $0.00 | $0.00 |
DisclosureSEC source: 0000063754-18-000122 · edgar.xml · derivative · entry 5 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 572 Underlying: Common Stock - Voting · 286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted Stock Units; no purchase price required. F6 · price: Restricted Stock Units granted on March 29, 2017. F5 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three year period beginning March 15, 2018, March 15, 2019 and March 15, 2020 but are subject to deferred delivery based on certain termination of service events. F5 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three year period beginning March 15, 2018, March 15, 2019 and March 15, 2020 but are subject to deferred delivery based on certain termination of service events. Read SEC document |
| March 15, 2018 Filed Dec 13, 2018 20:55 UTC Amendment | MCCORMICK & CO INC MKC · Entity 1416 | Exercise / conversionCommon Stock - Voting | 286 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000063754-18-000122 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Subject to deferred receipt. F3 · price: Restricted Stock Units; no purchase price required. F2 · balance_after: This amendment amends the Form 4 filed by the reporting person on March 19, 2018. The original Form 4 incorrectly reported a disposition of 138 shares, which transaction did not in fact occur. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 23:04 UTC Amendment | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 2,644 | $103.20 | $272,860.80 |
DisclosureSEC source: 0001314598-18-000031 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,518 F1 · shares: Shares withheld for taxes on the shares previously reported on 1/24/2018 for McCormick's long-term incentive program. F3 · balance_after: Due to an administrative error 8,631 voting shares were not reported in the previous Form 4. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 22:18 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 2,644 | $103.20 | $272,860.80 |
DisclosureSEC source: 0001314598-18-000026 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,887 F1 · shares: Shares withheld for taxes on the shares previously reported on 1/24/2018 for McCormick's long-term incentive program. Read SEC document |
| January 22, 2018 Filed Jan 24, 2018 17:31 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantCommon Stock - Voting | 8,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001314598-18-000011 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,162 F1 · shares: Shares awarded pursuant to McCormick's long-term incentive program for the three year performance cycle beginning on December 1, 2014 and ending on November 30, 2017. Read SEC document |
| January 16, 2018 Filed Jan 22, 2018 17:16 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 71.3963 | $101.29 | $7,231.73 |
DisclosureSEC source: 0001314598-18-000004 · edgar.xml · derivative · entry 5 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Compensation Plan Disclosed balance after: 13,978.5341 Underlying: Common Stock - Voting · 71.3963 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment F1 · derivative.exercise_date: Dividend Reinvestment F1 · derivative.expiration_date: Dividend Reinvestment Read SEC document |
| October 24, 2017 Filed Jan 22, 2018 17:16 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 65.6065 | $99.16 | $6,505.54 |
DisclosureSEC source: 0001314598-18-000004 · edgar.xml · derivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Compensation Plan Disclosed balance after: 13,907.1378 Underlying: Common Stock - Voting · 65.6065 shares Expires not disclosed F1 · derivative.exercise_price: Dividend Reinvestment F1 · derivative.exercise_date: Dividend Reinvestment F1 · derivative.expiration_date: Dividend Reinvestment Read SEC document |
| July 20, 2017 Filed Jul 24, 2017 17:30 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherPhantom Stock · Derivative | 13,841.5313 | $92.48 | $1,280,064.81 |
DisclosureSEC source: 0001314598-17-000063 · edgar.xml · derivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Compensation Plan Disclosed balance after: 13,841.5313 Underlying: Common Stock - Voting · 13,841.5313 shares Expires not disclosed F2 · derivative.exercise_price: Each share of phantom stock represents the right to receive one share of Common Stock - Voting. Shares of phantom stock are payable in shares of Comon Stock - Voting in accordance with the terms of the Deferred Compensation Plan. F2 · derivative.exercise_date: Each share of phantom stock represents the right to receive one share of Common Stock - Voting. Shares of phantom stock are payable in shares of Comon Stock - Voting in accordance with the terms of the Deferred Compensation Plan. F2 · derivative.expiration_date: Each share of phantom stock represents the right to receive one share of Common Stock - Voting. Shares of phantom stock are payable in shares of Comon Stock - Voting in accordance with the terms of the Deferred Compensation Plan. Read SEC document |
| July 20, 2017 Filed Jul 24, 2017 17:30 UTC | MCCORMICK & CO INC MKC · Entity 1416 | OtherCommon Stock - Voting | 930.5543 | $92.61 | $86,178.63 |
DisclosureSEC source: 0001314598-17-000063 · edgar.xml · nonDerivative · entry 3 Kurzius Lawrence Erik · CIK 0001352090 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) Retirement Plan Disclosed balance after: 6,967.2418 F1 · balance_after: Shares acquired under McCormick's 401(k) Plan. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 16:42 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantRestricted Stock Units · Derivative | 858 | $0.00 | $0.00 |
DisclosureSEC source: 0001314598-17-000033 · edgar.xml · derivative · entry 5 Kurzius Lawrence Erik · CIK 0001352090 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 858 Underlying: Common Stock - Voting · 858 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in thirds over a three year period beginning March 15, 2018, March 15, 2019 and March 15, 2020. F3 · derivative.expiration_date: The Restricted Stock Units vest in thirds over a three year period beginning March 15, 2018, March 15, 2019 and March 15, 2020. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 16:42 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantOptions - Right to Buy · Derivative | 127,769 | $0.00 Strike: $98.05 | $0.00 |
DisclosureSEC source: 0001314598-17-000033 · edgar.xml · derivative · entry 4 Kurzius Lawrence Erik · CIK 0001352090 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,769 Underlying: Common Stock - Voting · 127,769 shares Expires 2027-03-28 F1 · derivative.exercise_date: The option grant becomes exercisable in thirds at each of the first three (3) grant anniversaries. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 15:16 UTC | MCCORMICK & CO INC MKC · Entity 1416 | Tax withholdingCommon Stock - Voting | 1,321 | $97.14 | $128,321.94 |
DisclosureSEC source: 0001314598-17-000016 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,127 F1 · shares: Shares withheld for taxes on the shares previously reported on 01/25/2017 for the McCormick long-term incentive award. Read SEC document |
| January 23, 2017 Filed Jan 25, 2017 19:06 UTC | MCCORMICK & CO INC MKC · Entity 1416 | GrantCommon Stock - Voting | 3,672 | $0.00 | $0.00 |
DisclosureSEC source: 0001314598-17-000006 · edgar.xml · nonDerivative · entry 1 Kurzius Lawrence Erik · CIK 0001352090 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,448 F1 · shares: Shares awarded pursuant to McCormick's long-term incentive program for the three year performance cycle beginning on December 1, 2013 and ending on November 30, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.